AYTU
AYTU BIOPHARMA, INC
Key Financials
Net Income
$-14252000
↓ 5.1%
Revenue
$57.6M
↓ 13.3%
Total Liabilities
$97.1M
↑ 6.1%
Operating Income
$-8315000
↓ 6.2%
Total Assets
$105.0M
↓ 15.4%
Shareholders' Equity
$35.3M
↑ 86.0%
Gross Profit
$36.8M
↓ 19.7%
EPS (Diluted)
$-5.11
↓ 36.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 9/22/2026 | View on SEC |
| 8-K | 9/22/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 4 | 7/30/2026 | View on SEC |
| 4 | 7/30/2026 | View on SEC |
| 4 | 7/30/2026 | View on SEC |
| 4 | 7/30/2026 | View on SEC |
| 4 | 7/30/2026 | View on SEC |
| 4 | 7/30/2026 | View on SEC |
| 4 | 7/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AYTU |
| Company Name | AYTU BIOPHARMA, INC |
| CIK | 1385818 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | (720) 437-6580 |